

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | alpha-linolenic acid metabolic process (GO:0036109) | 4.16365193 |
| 2 | lysine catabolic process (GO:0006554) | 3.64766010 |
| 3 | lysine metabolic process (GO:0006553) | 3.64766010 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 3.30101495 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.30101495 |
| 6 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.26332596 |
| 7 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.19989171 |
| 8 | 2-oxoglutarate metabolic process (GO:0006103) | 3.19295104 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.19095247 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 3.19095247 |
| 11 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.18211850 |
| 12 | regulation of cholesterol homeostasis (GO:2000188) | 3.15795365 |
| 13 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.13561835 |
| 14 | sulfur amino acid catabolic process (GO:0000098) | 3.09784150 |
| 15 | synaptic vesicle maturation (GO:0016188) | 3.04939438 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.03464109 |
| 17 | cellular potassium ion homeostasis (GO:0030007) | 3.01872629 |
| 18 | fatty acid transmembrane transport (GO:1902001) | 2.94062669 |
| 19 | cerebellar granule cell differentiation (GO:0021707) | 2.91536116 |
| 20 | low-density lipoprotein particle clearance (GO:0034383) | 2.84223415 |
| 21 | kynurenine metabolic process (GO:0070189) | 2.81341887 |
| 22 | tricarboxylic acid metabolic process (GO:0072350) | 2.80321685 |
| 23 | complement activation, alternative pathway (GO:0006957) | 2.79982051 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 2.79158172 |
| 25 | positive regulation of lipid catabolic process (GO:0050996) | 2.78238500 |
| 26 | carnitine shuttle (GO:0006853) | 2.76524513 |
| 27 | macroautophagy (GO:0016236) | 2.75363221 |
| 28 | cellular modified amino acid catabolic process (GO:0042219) | 2.75060540 |
| 29 | protein localization to endosome (GO:0036010) | 2.75010798 |
| 30 | positive regulation of fatty acid oxidation (GO:0046321) | 2.74611918 |
| 31 | cysteine metabolic process (GO:0006534) | 2.73881480 |
| 32 | glutamate metabolic process (GO:0006536) | 2.72993992 |
| 33 | sodium ion export (GO:0071436) | 2.72669151 |
| 34 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.72053179 |
| 35 | activation of protein kinase A activity (GO:0034199) | 2.71779828 |
| 36 | urea cycle (GO:0000050) | 2.71757127 |
| 37 | urea metabolic process (GO:0019627) | 2.71757127 |
| 38 | aspartate family amino acid catabolic process (GO:0009068) | 2.69974681 |
| 39 | aromatic amino acid family catabolic process (GO:0009074) | 2.69866805 |
| 40 | valine metabolic process (GO:0006573) | 2.69844180 |
| 41 | alanine transport (GO:0032328) | 2.69652240 |
| 42 | regulation of early endosome to late endosome transport (GO:2000641) | 2.68972735 |
| 43 | locomotory exploration behavior (GO:0035641) | 2.68156309 |
| 44 | regulation of fatty acid oxidation (GO:0046320) | 2.67814498 |
| 45 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.66948371 |
| 46 | bile acid biosynthetic process (GO:0006699) | 2.65816045 |
| 47 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.65728949 |
| 48 | glyoxylate metabolic process (GO:0046487) | 2.61481860 |
| 49 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.61029188 |
| 50 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.60873977 |
| 51 | protein carboxylation (GO:0018214) | 2.60873977 |
| 52 | Golgi transport vesicle coating (GO:0048200) | 2.58993785 |
| 53 | COPI coating of Golgi vesicle (GO:0048205) | 2.58993785 |
| 54 | plasma lipoprotein particle clearance (GO:0034381) | 2.58841552 |
| 55 | cellular ketone body metabolic process (GO:0046950) | 2.58544203 |
| 56 | desmosome organization (GO:0002934) | 2.58490550 |
| 57 | oxaloacetate metabolic process (GO:0006107) | 2.57536922 |
| 58 | plasma membrane repair (GO:0001778) | 2.57132510 |
| 59 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.55845246 |
| 60 | regulation of protein activation cascade (GO:2000257) | 2.54021475 |
| 61 | high-density lipoprotein particle remodeling (GO:0034375) | 2.52335926 |
| 62 | phospholipid homeostasis (GO:0055091) | 2.52092543 |
| 63 | adherens junction assembly (GO:0034333) | 2.49536923 |
| 64 | regulation of cholesterol storage (GO:0010885) | 2.49396770 |
| 65 | negative regulation of cell size (GO:0045792) | 2.48729615 |
| 66 | cell-substrate adherens junction assembly (GO:0007045) | 2.47246131 |
| 67 | focal adhesion assembly (GO:0048041) | 2.47246131 |
| 68 | amino-acid betaine metabolic process (GO:0006577) | 2.45666189 |
| 69 | regulation of complement activation (GO:0030449) | 2.45236394 |
| 70 | fatty acid homeostasis (GO:0055089) | 2.45187830 |
| 71 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.44361151 |
| 72 | protein targeting to plasma membrane (GO:0072661) | 2.44133223 |
| 73 | dicarboxylic acid catabolic process (GO:0043649) | 2.43118177 |
| 74 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.42831121 |
| 75 | cell communication by electrical coupling (GO:0010644) | 2.41965562 |
| 76 | reverse cholesterol transport (GO:0043691) | 2.41475072 |
| 77 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.41467167 |
| 78 | fatty acid beta-oxidation (GO:0006635) | 2.41359652 |
| 79 | regulation of triglyceride catabolic process (GO:0010896) | 2.41241448 |
| 80 | cellular response to catecholamine stimulus (GO:0071870) | 2.41142267 |
| 81 | cellular response to monoamine stimulus (GO:0071868) | 2.41142267 |
| 82 | synaptic vesicle exocytosis (GO:0016079) | 2.40412508 |
| 83 | positive regulation of receptor recycling (GO:0001921) | 2.39855210 |
| 84 | nitrogen cycle metabolic process (GO:0071941) | 2.39730684 |
| 85 | negative regulation of sterol transport (GO:0032372) | 2.39176408 |
| 86 | negative regulation of cholesterol transport (GO:0032375) | 2.39176408 |
| 87 | L-amino acid import (GO:0043092) | 2.36385382 |
| 88 | homocysteine metabolic process (GO:0050667) | 2.36180206 |
| 89 | acetyl-CoA metabolic process (GO:0006084) | 2.35707355 |
| 90 | neutral lipid catabolic process (GO:0046461) | 2.34996725 |
| 91 | acylglycerol catabolic process (GO:0046464) | 2.34996725 |
| 92 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.33989918 |
| 93 | barbed-end actin filament capping (GO:0051016) | 2.33382676 |
| 94 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.33230464 |
| 95 | regulation of lipid catabolic process (GO:0050994) | 2.31961692 |
| 96 | regulation of synapse structural plasticity (GO:0051823) | 2.31157840 |
| 97 | cell communication involved in cardiac conduction (GO:0086065) | 2.31134456 |
| 98 | regulation of ARF protein signal transduction (GO:0032012) | 2.30628070 |
| 99 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.30335921 |
| 100 | fatty acid oxidation (GO:0019395) | 2.30189939 |
| 101 | signal complex assembly (GO:0007172) | 2.29618274 |
| 102 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.29288646 |
| 103 | ketone body metabolic process (GO:1902224) | 2.28994759 |
| 104 | bile acid metabolic process (GO:0008206) | 2.28838291 |
| 105 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.28680436 |
| 106 | negative regulation of lipid transport (GO:0032369) | 2.28354317 |
| 107 | lipid oxidation (GO:0034440) | 2.27702422 |
| 108 | proline transport (GO:0015824) | 2.27432766 |
| 109 | stress fiber assembly (GO:0043149) | 2.27283356 |
| 110 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.27034669 |
| 111 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.26843478 |
| 112 | cell-substrate junction assembly (GO:0007044) | 2.26813556 |
| 113 | amino acid import (GO:0043090) | 2.25928065 |
| 114 | glutamate secretion (GO:0014047) | 2.24361784 |
| 115 | ethanol oxidation (GO:0006069) | 2.23425050 |
| 116 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.22839404 |
| 117 | regulation of synaptic vesicle transport (GO:1902803) | 2.22732503 |
| 118 | regulation of fibrinolysis (GO:0051917) | 2.22580742 |
| 119 | growth hormone receptor signaling pathway (GO:0060396) | 2.22305455 |
| 120 | apoptotic cell clearance (GO:0043277) | 2.21365132 |
| 121 | short-chain fatty acid metabolic process (GO:0046459) | 2.21220598 |
| 122 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.21202904 |
| 123 | indolalkylamine catabolic process (GO:0046218) | 2.21173058 |
| 124 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.16809192 |
| 125 | positive regulation of Rap GTPase activity (GO:0032854) | 2.13448627 |
| 126 | cellular sodium ion homeostasis (GO:0006883) | 2.13249652 |
| 127 | surfactant homeostasis (GO:0043129) | 2.11798366 |
| 128 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.08971161 |
| 129 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.07683335 |
| 130 | cellular response to epinephrine stimulus (GO:0071872) | 2.07593823 |
| 131 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.06638864 |
| 132 | regulation of extracellular matrix disassembly (GO:0010715) | 2.03783788 |
| 133 | response to monoamine (GO:0071867) | 2.03782032 |
| 134 | response to catecholamine (GO:0071869) | 2.03782032 |
| 135 | myelin maintenance (GO:0043217) | 2.03671963 |
| 136 | potassium ion homeostasis (GO:0055075) | 2.03204192 |
| 137 | mating behavior (GO:0007617) | 2.01346999 |
| 138 | hypotonic response (GO:0006971) | 2.00896951 |
| 139 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.00006239 |
| 140 | negative regulation of fatty acid transport (GO:2000192) | 1.99415705 |
| 141 | positive regulation of cellular amide metabolic process (GO:0034250) | 1.99252674 |
| 142 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 1.99028050 |
| 143 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 1.98157859 |
| 144 | neuromuscular process controlling balance (GO:0050885) | 1.98029526 |
| 145 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 1.97836993 |
| 146 | layer formation in cerebral cortex (GO:0021819) | 1.97800528 |
| 147 | cell-cell junction maintenance (GO:0045217) | 1.97626735 |
| 148 | regulation of water loss via skin (GO:0033561) | 1.96864332 |
| 149 | protein retention in ER lumen (GO:0006621) | 1.96530808 |
| 150 | semaphorin-plexin signaling pathway (GO:0071526) | 1.95598634 |
| 151 | actin filament depolymerization (GO:0030042) | 1.93662006 |
| 152 | regulation of ARF GTPase activity (GO:0032312) | 1.93310288 |
| 153 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 1.92982862 |
| 154 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 1.92518207 |
| 155 | positive regulation of synapse maturation (GO:0090129) | 1.92308287 |
| 156 | establishment of protein localization to plasma membrane (GO:0090002) | 1.91750169 |
| 157 | skin morphogenesis (GO:0043589) | 1.91574088 |
| 158 | potassium ion import (GO:0010107) | 1.91023569 |
| 159 | negative regulation of catenin import into nucleus (GO:0035414) | 1.89611186 |
| 160 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 1.89235015 |
| 161 | response to parathyroid hormone (GO:0071107) | 1.88902960 |
| 162 | import into cell (GO:0098657) | 1.88519684 |
| 163 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 1.88402642 |
| 164 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 1.88294763 |
| 165 | dopamine receptor signaling pathway (GO:0007212) | 1.87354687 |
| 166 | response to laminar fluid shear stress (GO:0034616) | 1.86705372 |
| 167 | apical protein localization (GO:0045176) | 1.86163049 |
| 168 | regulation of neuronal synaptic plasticity (GO:0048168) | 1.85833479 |
| 169 | cortical actin cytoskeleton organization (GO:0030866) | 1.85035736 |
| 170 | regulation of T-helper 2 cell differentiation (GO:0045628) | 1.84919993 |
| 171 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 1.84845458 |
| 172 | mannose metabolic process (GO:0006013) | 1.84017240 |
| 173 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 1.83866223 |
| 174 | basement membrane organization (GO:0071711) | 1.82824521 |
| 175 | maternal placenta development (GO:0001893) | 1.82401090 |
| 176 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 1.82353090 |
| 177 | epithelial cell-cell adhesion (GO:0090136) | 1.82194148 |
| 178 | multicellular organismal water homeostasis (GO:0050891) | 1.80981680 |
| 179 | regulation of Rap GTPase activity (GO:0032317) | 1.80724569 |
| 180 | regulation of beta-amyloid formation (GO:1902003) | 1.78950294 |
| 181 | antigen processing and presentation of endogenous antigen (GO:0019883) | 1.78472482 |
| 182 | negative regulation of cell killing (GO:0031342) | 1.78302760 |
| 183 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 1.78302760 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.81125436 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.73205766 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.58102241 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.15003576 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.03482741 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.64579423 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.38102637 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.38006041 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.32542205 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.05859246 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.05603534 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.89547276 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.84552562 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.80188837 |
| 15 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.71744788 |
| 16 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.68459001 |
| 17 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.67405081 |
| 18 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.63574909 |
| 19 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.62209102 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.57680653 |
| 21 | KDM2B_26808549_Chip-Seq_K562_Human | 1.55970243 |
| 22 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.54587582 |
| 23 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.50477998 |
| 24 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.47902330 |
| 25 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.47511849 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.46506067 |
| 27 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.42360862 |
| 28 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.40946206 |
| 29 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.40774936 |
| 30 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.37219167 |
| 31 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.36743053 |
| 32 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.36362959 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35438415 |
| 34 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.34152919 |
| 35 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.32057334 |
| 36 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.30873480 |
| 37 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.30583318 |
| 38 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29125816 |
| 39 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.26623985 |
| 40 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.23770688 |
| 41 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.21272556 |
| 42 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21271425 |
| 43 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.20475823 |
| 44 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19776543 |
| 45 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.19384516 |
| 46 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.18462191 |
| 47 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18030376 |
| 48 | GATA1_22025678_ChIP-Seq_K562_Human | 1.17178848 |
| 49 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.17150276 |
| 50 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16807323 |
| 51 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.15179208 |
| 52 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.15179208 |
| 53 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.14787477 |
| 54 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.14445325 |
| 55 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12893819 |
| 56 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.12424163 |
| 57 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.12082839 |
| 58 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11732521 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10973533 |
| 60 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.09386250 |
| 61 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.08389314 |
| 62 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08304127 |
| 63 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.07534796 |
| 64 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.07222918 |
| 65 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.07205228 |
| 66 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.06646549 |
| 67 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.05561625 |
| 68 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.05394671 |
| 69 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.05299588 |
| 70 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.04994910 |
| 71 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04156421 |
| 72 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.03378053 |
| 73 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03256064 |
| 74 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.02894404 |
| 75 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02634206 |
| 76 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.00958347 |
| 77 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00790419 |
| 78 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.00150772 |
| 79 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.99799016 |
| 80 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.99732560 |
| 81 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.99687084 |
| 82 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.99687084 |
| 83 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99060946 |
| 84 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.98820955 |
| 85 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.98619485 |
| 86 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.98460811 |
| 87 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.98204580 |
| 88 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.97813096 |
| 89 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.97770312 |
| 90 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.96962102 |
| 91 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96820734 |
| 92 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.96052365 |
| 93 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95907035 |
| 94 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.95438046 |
| 95 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95176810 |
| 96 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.94272976 |
| 97 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.92931787 |
| 98 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.92863303 |
| 99 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.92252747 |
| 100 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92238575 |
| 101 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91840943 |
| 102 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.91727314 |
| 103 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91030769 |
| 104 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.90850267 |
| 105 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90551679 |
| 106 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.90454492 |
| 107 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.89622443 |
| 108 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89618109 |
| 109 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.89134535 |
| 110 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.89028460 |
| 111 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.87623298 |
| 112 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.87600236 |
| 113 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.87385951 |
| 114 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.86714629 |
| 115 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.85588639 |
| 116 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.85294153 |
| 117 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.85164577 |
| 118 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85120378 |
| 119 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.84678510 |
| 120 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83929881 |
| 121 | SPI1_23127762_ChIP-Seq_K562_Human | 0.83836391 |
| 122 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.83455578 |
| 123 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.82693097 |
| 124 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82239854 |
| 125 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.80730048 |
| 126 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.79916019 |
| 127 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79720122 |
| 128 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78812515 |
| 129 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.78063104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.13977916 |
| 2 | MP0005360_urolithiasis | 3.73785128 |
| 3 | MP0005365_abnormal_bile_salt | 3.37151803 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.09383555 |
| 5 | MP0005409_darkened_coat_color | 3.06200709 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.87405236 |
| 7 | MP0004130_abnormal_muscle_cell | 2.76452952 |
| 8 | MP0004859_abnormal_synaptic_plasticity | 2.70528075 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.54336056 |
| 10 | MP0009840_abnormal_foam_cell | 2.54304952 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.38920563 |
| 12 | MP0003252_abnormal_bile_duct | 2.38325529 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.29559268 |
| 14 | MP0005083_abnormal_biliary_tract | 2.24612853 |
| 15 | MP0002909_abnormal_adrenal_gland | 2.23239091 |
| 16 | MP0009780_abnormal_chondrocyte_physiolo | 2.08725241 |
| 17 | MP0004858_abnormal_nervous_system | 2.00852432 |
| 18 | MP0002796_impaired_skin_barrier | 1.97996815 |
| 19 | MP0003300_gastrointestinal_ulcer | 1.95433100 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.85418669 |
| 21 | MP0008961_abnormal_basal_metabolism | 1.80354127 |
| 22 | MP0003329_amyloid_beta_deposits | 1.79390809 |
| 23 | MP0005058_abnormal_lysosome_morphology | 1.77999156 |
| 24 | MP0005451_abnormal_body_composition | 1.77040137 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.67461975 |
| 26 | MP0000604_amyloidosis | 1.67431369 |
| 27 | MP0005332_abnormal_amino_acid | 1.61739273 |
| 28 | MP0000013_abnormal_adipose_tissue | 1.59875486 |
| 29 | MP0000751_myopathy | 1.58401503 |
| 30 | MP0003172_abnormal_lysosome_physiology | 1.54671123 |
| 31 | MP0008569_lethality_at_weaning | 1.54637072 |
| 32 | MP0010234_abnormal_vibrissa_follicle | 1.54581483 |
| 33 | MP0003279_aneurysm | 1.51067122 |
| 34 | MP0003195_calcinosis | 1.49538055 |
| 35 | MP0004264_abnormal_extraembryonic_tissu | 1.45223451 |
| 36 | MP0008260_abnormal_autophagy | 1.44139141 |
| 37 | MP0003075_altered_response_to | 1.43235029 |
| 38 | MP0003303_peritoneal_inflammation | 1.42285315 |
| 39 | MP0000609_abnormal_liver_physiology | 1.41622616 |
| 40 | MP0000920_abnormal_myelination | 1.39916991 |
| 41 | MP0001666_abnormal_nutrient_absorption | 1.38695109 |
| 42 | MP0003453_abnormal_keratinocyte_physiol | 1.37149643 |
| 43 | MP0005423_abnormal_somatic_nervous | 1.36474851 |
| 44 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.35413603 |
| 45 | MP0005167_abnormal_blood-brain_barrier | 1.34827505 |
| 46 | MP0005319_abnormal_enzyme/_coenzyme | 1.32574516 |
| 47 | MP0003690_abnormal_glial_cell | 1.31738697 |
| 48 | MP0004270_analgesia | 1.29587291 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.29508404 |
| 50 | MP0005666_abnormal_adipose_tissue | 1.26244273 |
| 51 | MP0005503_abnormal_tendon_morphology | 1.24251263 |
| 52 | MP0006138_congestive_heart_failure | 1.23606937 |
| 53 | MP0001348_abnormal_lacrimal_gland | 1.23256962 |
| 54 | MP0004381_abnormal_hair_follicle | 1.22413568 |
| 55 | MP0004084_abnormal_cardiac_muscle | 1.21756852 |
| 56 | MP0002877_abnormal_melanocyte_morpholog | 1.18016352 |
| 57 | MP0005670_abnormal_white_adipose | 1.17928530 |
| 58 | MP0008004_abnormal_stomach_pH | 1.16511543 |
| 59 | MP0002269_muscular_atrophy | 1.16280527 |
| 60 | MP0000747_muscle_weakness | 1.15830642 |
| 61 | MP0004087_abnormal_muscle_fiber | 1.15521102 |
| 62 | MP0004947_skin_inflammation | 1.15459385 |
| 63 | MP0002078_abnormal_glucose_homeostasis | 1.15248225 |
| 64 | MP0004185_abnormal_adipocyte_glucose | 1.14277621 |
| 65 | MP0003635_abnormal_synaptic_transmissio | 1.13955292 |
| 66 | MP0002138_abnormal_hepatobiliary_system | 1.12217795 |
| 67 | MP0003634_abnormal_glial_cell | 1.11113177 |
| 68 | MP0005375_adipose_tissue_phenotype | 1.10312836 |
| 69 | MP0005023_abnormal_wound_healing | 1.09467310 |
| 70 | MP0000569_abnormal_digit_pigmentation | 1.09433657 |
| 71 | MP0004036_abnormal_muscle_relaxation | 1.08160231 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 1.08130759 |
| 73 | MP0005535_abnormal_body_temperature | 1.07048975 |
| 74 | MP0003828_pulmonary_edema | 1.06285020 |
| 75 | MP0001756_abnormal_urination | 1.06209002 |
| 76 | MP0000003_abnormal_adipose_tissue | 1.06138027 |
| 77 | MP0008438_abnormal_cutaneous_collagen | 1.04652357 |
| 78 | MP0000579_abnormal_nail_morphology | 1.03534463 |
| 79 | MP0003566_abnormal_cell_adhesion | 1.02959420 |
| 80 | MP0003045_fibrosis | 1.02263779 |
| 81 | MP0009643_abnormal_urine_homeostasis | 1.01872802 |
| 82 | MP0003633_abnormal_nervous_system | 1.00346474 |
| 83 | MP0004019_abnormal_vitamin_homeostasis | 0.99796874 |
| 84 | MP0005257_abnormal_intraocular_pressure | 0.97362668 |
| 85 | MP0003806_abnormal_nucleotide_metabolis | 0.95274840 |
| 86 | MP0000566_synostosis | 0.94651995 |
| 87 | MP0002971_abnormal_brown_adipose | 0.93880040 |
| 88 | MP0002998_abnormal_bone_remodeling | 0.93693603 |
| 89 | MP0004043_abnormal_pH_regulation | 0.93209820 |
| 90 | MP0001851_eye_inflammation | 0.92342229 |
| 91 | MP0003283_abnormal_digestive_organ | 0.90525079 |
| 92 | MP0004885_abnormal_endolymph | 0.90213219 |
| 93 | MP0001849_ear_inflammation | 0.90111124 |
| 94 | MP0004233_abnormal_muscle_weight | 0.89268434 |
| 95 | MP0000534_abnormal_ureter_morphology | 0.88814307 |
| 96 | MP0000759_abnormal_skeletal_muscle | 0.86863611 |
| 97 | MP0005334_abnormal_fat_pad | 0.86750150 |
| 98 | MP0002090_abnormal_vision | 0.86594084 |
| 99 | MP0002133_abnormal_respiratory_system | 0.86338995 |
| 100 | MP0005388_respiratory_system_phenotype | 0.86338995 |
| 101 | MP0003436_decreased_susceptibility_to | 0.86151621 |
| 102 | MP0004272_abnormal_basement_membrane | 0.84508087 |
| 103 | MP0003724_increased_susceptibility_to | 0.84298314 |
| 104 | MP0005166_decreased_susceptibility_to | 0.84230121 |
| 105 | MP0002822_catalepsy | 0.83986350 |
| 106 | MP0002089_abnormal_postnatal_growth/wei | 0.83939774 |
| 107 | MP0004510_myositis | 0.83238423 |
| 108 | MP0000678_abnormal_parathyroid_gland | 0.83122444 |
| 109 | MP0001958_emphysema | 0.81239354 |
| 110 | MP0002063_abnormal_learning/memory/cond | 0.79887980 |
| 111 | MP0000767_abnormal_smooth_muscle | 0.79753136 |
| 112 | MP0004484_altered_response_of | 0.79401263 |
| 113 | MP0005076_abnormal_cell_differentiation | 0.78262155 |
| 114 | MP0005464_abnormal_platelet_physiology | 0.78247471 |
| 115 | MP0005248_abnormal_Harderian_gland | 0.78244283 |
| 116 | MP0008874_decreased_physiological_sensi | 0.77477224 |
| 117 | MP0003646_muscle_fatigue | 0.77276177 |
| 118 | MP0001502_abnormal_circadian_rhythm | 0.77201586 |
| 119 | MP0001346_abnormal_lacrimal_gland | 0.77007994 |
| 120 | MP0002734_abnormal_mechanical_nocicepti | 0.76697479 |
| 121 | MP0005501_abnormal_skin_physiology | 0.76664152 |
| 122 | MP0000733_abnormal_muscle_development | 0.76301963 |
| 123 | MP0002972_abnormal_cardiac_muscle | 0.76220907 |
| 124 | MP0005620_abnormal_muscle_contractility | 0.75752659 |
| 125 | MP0005448_abnormal_energy_balance | 0.74972183 |
| 126 | MP0002249_abnormal_larynx_morphology | 0.74558403 |
| 127 | MP0000749_muscle_degeneration | 0.74434180 |
| 128 | MP0005275_abnormal_skin_tensile | 0.73621028 |
| 129 | MP0001533_abnormal_skeleton_physiology | 0.73468129 |
| 130 | MP0003868_abnormal_feces_composition | 0.72457293 |
| 131 | MP0005330_cardiomyopathy | 0.71805219 |
| 132 | MP0002896_abnormal_bone_mineralization | 0.71275276 |
| 133 | MP0004811_abnormal_neuron_physiology | 0.70328415 |
| 134 | MP0000598_abnormal_liver_morphology | 0.70280632 |
| 135 | MP0002168_other_aberrant_phenotype | 0.70036171 |
| 136 | MP0001765_abnormal_ion_homeostasis | 0.70029584 |
| 137 | MP0000377_abnormal_hair_follicle | 0.69387406 |
| 138 | MP0009384_cardiac_valve_regurgitation | 0.68507006 |
| 139 | MP0004782_abnormal_surfactant_physiolog | 0.68057099 |
| 140 | MP0002064_seizures | 0.67691862 |
| 141 | MP0005623_abnormal_meninges_morphology | 0.67537477 |
| 142 | MP0002060_abnormal_skin_morphology | 0.67371182 |
| 143 | MP0010630_abnormal_cardiac_muscle | 0.67256824 |
| 144 | MP0002108_abnormal_muscle_morphology | 0.67102243 |
| 145 | MP0003091_abnormal_cell_migration | 0.66433316 |
| 146 | MP0002098_abnormal_vibrissa_morphology | 0.66395521 |
| 147 | MP0001544_abnormal_cardiovascular_syste | 0.66394040 |
| 148 | MP0005385_cardiovascular_system_phenoty | 0.66394040 |
| 149 | MP0004215_abnormal_myocardial_fiber | 0.66198258 |
| 150 | MP0003879_abnormal_hair_cell | 0.65868113 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 3.84884206 |
| 2 | Obstructive sleep apnea (HP:0002870) | 3.48836266 |
| 3 | Xanthomatosis (HP:0000991) | 3.18071138 |
| 4 | Protrusio acetabuli (HP:0003179) | 3.07557868 |
| 5 | Neurofibrillary tangles (HP:0002185) | 3.06961608 |
| 6 | Complement deficiency (HP:0004431) | 2.99808959 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.83851128 |
| 8 | Ketosis (HP:0001946) | 2.82599317 |
| 9 | Arterial tortuosity (HP:0005116) | 2.81820435 |
| 10 | Ketoacidosis (HP:0001993) | 2.76159071 |
| 11 | Vascular tortuosity (HP:0004948) | 2.73460255 |
| 12 | Gout (HP:0001997) | 2.65154224 |
| 13 | Hypoglycemic coma (HP:0001325) | 2.59968910 |
| 14 | Abnormality of the lower motor neuron (HP:0002366) | 2.53644161 |
| 15 | Intrahepatic cholestasis (HP:0001406) | 2.52024028 |
| 16 | Increased variability in muscle fiber diameter (HP:0003557) | 2.50669500 |
| 17 | Distal lower limb muscle weakness (HP:0009053) | 2.48100741 |
| 18 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.45830989 |
| 19 | Hyperlipoproteinemia (HP:0010980) | 2.39009358 |
| 20 | Cerebral aneurysm (HP:0004944) | 2.35901846 |
| 21 | Hyperammonemia (HP:0001987) | 2.34930860 |
| 22 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.31725428 |
| 23 | Exercise-induced myalgia (HP:0003738) | 2.31218282 |
| 24 | Long toe (HP:0010511) | 2.28797640 |
| 25 | Type 1 muscle fiber predominance (HP:0003803) | 2.28191174 |
| 26 | Myoglobinuria (HP:0002913) | 2.27845964 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 2.25646772 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.24418774 |
| 29 | Epidermoid cyst (HP:0200040) | 2.24237100 |
| 30 | Ankle clonus (HP:0011448) | 2.22921707 |
| 31 | Flat acetabular roof (HP:0003180) | 2.22234653 |
| 32 | Skin nodule (HP:0200036) | 2.21624551 |
| 33 | Lymphangioma (HP:0100764) | 2.21349863 |
| 34 | Asymmetric septal hypertrophy (HP:0001670) | 2.21152378 |
| 35 | Abnormality of the common coagulation pathway (HP:0010990) | 2.18645581 |
| 36 | Mitral stenosis (HP:0001718) | 2.18570095 |
| 37 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.17023973 |
| 38 | Upper limb amyotrophy (HP:0009129) | 2.16543292 |
| 39 | Distal upper limb amyotrophy (HP:0007149) | 2.16543292 |
| 40 | Eczematoid dermatitis (HP:0000976) | 2.14814881 |
| 41 | Aortic aneurysm (HP:0004942) | 2.13761406 |
| 42 | Exercise-induced muscle cramps (HP:0003710) | 2.13638475 |
| 43 | Hyporeflexia of lower limbs (HP:0002600) | 2.13240601 |
| 44 | Abnormality of complement system (HP:0005339) | 2.11408549 |
| 45 | Hyperglycinuria (HP:0003108) | 2.11264602 |
| 46 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.10790146 |
| 47 | Mucopolysacchariduria (HP:0008155) | 2.10790146 |
| 48 | Increased cerebral lipofuscin (HP:0011813) | 2.08786378 |
| 49 | Bundle branch block (HP:0011710) | 2.08173799 |
| 50 | Action tremor (HP:0002345) | 2.08157912 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 2.07609977 |
| 52 | Turricephaly (HP:0000262) | 2.06931714 |
| 53 | Abnormality of the Achilles tendon (HP:0005109) | 2.06614931 |
| 54 | Diplopia (HP:0000651) | 2.06239757 |
| 55 | Abnormality of binocular vision (HP:0011514) | 2.06239757 |
| 56 | Premature rupture of membranes (HP:0001788) | 2.04968113 |
| 57 | Hand muscle atrophy (HP:0009130) | 2.04835507 |
| 58 | Enlarged penis (HP:0000040) | 2.04800539 |
| 59 | Myokymia (HP:0002411) | 2.04762107 |
| 60 | Muscle fiber splitting (HP:0003555) | 2.03503159 |
| 61 | Striae distensae (HP:0001065) | 2.03213318 |
| 62 | Increased IgE level (HP:0003212) | 2.02216890 |
| 63 | Hyperparathyroidism (HP:0000843) | 2.02094165 |
| 64 | Supranuclear gaze palsy (HP:0000605) | 2.02067330 |
| 65 | Difficulty running (HP:0009046) | 2.01725672 |
| 66 | Neonatal onset (HP:0003623) | 2.01165949 |
| 67 | Shallow orbits (HP:0000586) | 2.01002763 |
| 68 | Distal lower limb amyotrophy (HP:0008944) | 2.00932208 |
| 69 | Broad metatarsal (HP:0001783) | 2.00088972 |
| 70 | Visual hallucinations (HP:0002367) | 1.99684039 |
| 71 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.98376060 |
| 72 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.98376060 |
| 73 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.98376060 |
| 74 | Abnormality of purine metabolism (HP:0004352) | 1.96534453 |
| 75 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.95891185 |
| 76 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.95092000 |
| 77 | Myocardial infarction (HP:0001658) | 1.94820046 |
| 78 | Aneurysm (HP:0002617) | 1.93706934 |
| 79 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.93489635 |
| 80 | Abnormality of glycine metabolism (HP:0010895) | 1.93337760 |
| 81 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.93337760 |
| 82 | Sensorimotor neuropathy (HP:0007141) | 1.92834583 |
| 83 | Resting tremor (HP:0002322) | 1.92560716 |
| 84 | Hypolipoproteinemia (HP:0010981) | 1.92465014 |
| 85 | Aortic dissection (HP:0002647) | 1.92257231 |
| 86 | Dysostosis multiplex (HP:0000943) | 1.91369237 |
| 87 | Dysmetric saccades (HP:0000641) | 1.89527924 |
| 88 | Polycythemia (HP:0001901) | 1.88876909 |
| 89 | Broad face (HP:0000283) | 1.88823583 |
| 90 | Vertebral compression fractures (HP:0002953) | 1.88116596 |
| 91 | Foot dorsiflexor weakness (HP:0009027) | 1.88014432 |
| 92 | Back pain (HP:0003418) | 1.87958955 |
| 93 | Sudden death (HP:0001699) | 1.87224985 |
| 94 | Cholelithiasis (HP:0001081) | 1.86001279 |
| 95 | Torticollis (HP:0000473) | 1.85913312 |
| 96 | Papilledema (HP:0001085) | 1.85285129 |
| 97 | Global brain atrophy (HP:0002283) | 1.84910569 |
| 98 | Hypobetalipoproteinemia (HP:0003563) | 1.84707844 |
| 99 | Hyperacusis (HP:0010780) | 1.84412915 |
| 100 | Hypercortisolism (HP:0001578) | 1.82108076 |
| 101 | Hyperglycinemia (HP:0002154) | 1.81519379 |
| 102 | Increased CSF protein (HP:0002922) | 1.81245413 |
| 103 | Achilles tendon contracture (HP:0001771) | 1.80776479 |
| 104 | Depression (HP:0000716) | 1.80768050 |
| 105 | Right ventricular cardiomyopathy (HP:0011663) | 1.80530189 |
| 106 | Abnormal atrioventricular conduction (HP:0005150) | 1.80509724 |
| 107 | Macroorchidism (HP:0000053) | 1.80105318 |
| 108 | Oligomenorrhea (HP:0000876) | 1.79799005 |
| 109 | Lower limb amyotrophy (HP:0007210) | 1.78878580 |
| 110 | Late onset (HP:0003584) | 1.78871572 |
| 111 | Thin bony cortex (HP:0002753) | 1.78577460 |
| 112 | Ventricular tachycardia (HP:0004756) | 1.77925730 |
| 113 | Frequent falls (HP:0002359) | 1.77131811 |
| 114 | Spastic diplegia (HP:0001264) | 1.76995721 |
| 115 | Abnormal gallbladder morphology (HP:0012437) | 1.76238594 |
| 116 | Abnormality of the intrinsic pathway (HP:0010989) | 1.75769486 |
| 117 | Atrioventricular block (HP:0001678) | 1.75593833 |
| 118 | Pheochromocytoma (HP:0002666) | 1.75296854 |
| 119 | Dilatation of the ascending aorta (HP:0005111) | 1.75089413 |
| 120 | Hypercholesterolemia (HP:0003124) | 1.74764045 |
| 121 | Heart block (HP:0012722) | 1.73670489 |
| 122 | Hypoglycemic seizures (HP:0002173) | 1.73460017 |
| 123 | Germ cell neoplasia (HP:0100728) | 1.73008042 |
| 124 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.72912542 |
| 125 | Ankyloglossia (HP:0010296) | 1.72396620 |
| 126 | Decreased motor nerve conduction velocity (HP:0003431) | 1.71952071 |
| 127 | Growth hormone excess (HP:0000845) | 1.71667681 |
| 128 | Hydroxyprolinuria (HP:0003080) | 1.71231258 |
| 129 | Abnormality of proline metabolism (HP:0010907) | 1.71231258 |
| 130 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.70879229 |
| 131 | Hamartoma of the eye (HP:0010568) | 1.69632995 |
| 132 | Postural instability (HP:0002172) | 1.69608095 |
| 133 | Increased connective tissue (HP:0009025) | 1.69058010 |
| 134 | Ventricular fibrillation (HP:0001663) | 1.68133372 |
| 135 | Cerebral inclusion bodies (HP:0100314) | 1.67368173 |
| 136 | Abnormality of the foot musculature (HP:0001436) | 1.67101184 |
| 137 | Axonal loss (HP:0003447) | 1.66629111 |
| 138 | Hyperglycemia (HP:0003074) | 1.66567070 |
| 139 | Esophageal varix (HP:0002040) | 1.66502690 |
| 140 | Onion bulb formation (HP:0003383) | 1.66474603 |
| 141 | Status epilepticus (HP:0002133) | 1.66303827 |
| 142 | Wormian bones (HP:0002645) | 1.65219834 |
| 143 | Rapidly progressive (HP:0003678) | 1.63879995 |
| 144 | Interstitial pulmonary disease (HP:0006530) | 1.63879417 |
| 145 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.63550591 |
| 146 | Cervical subluxation (HP:0003308) | 1.63416214 |
| 147 | Neonatal short-limb short stature (HP:0008921) | 1.63200213 |
| 148 | Sudden cardiac death (HP:0001645) | 1.62156672 |
| 149 | Spinal rigidity (HP:0003306) | 1.61001458 |
| 150 | Abnormality of the fingertips (HP:0001211) | 1.59599814 |
| 151 | Mitral regurgitation (HP:0001653) | 1.59518022 |
| 152 | Neuronal loss in central nervous system (HP:0002529) | 1.59177255 |
| 153 | Fragile skin (HP:0001030) | 1.58079484 |
| 154 | Bronchomalacia (HP:0002780) | 1.57720901 |
| 155 | Hypoplasia of the iris (HP:0007676) | 1.56049249 |
| 156 | Hammertoe (HP:0001765) | 1.55428113 |
| 157 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.54516281 |
| 158 | Aplasia of the phalanges of the hand (HP:0009802) | 1.54516281 |
| 159 | Aplasia involving bones of the extremities (HP:0009825) | 1.54516281 |
| 160 | Bladder diverticulum (HP:0000015) | 1.54030632 |
| 161 | Myopathic facies (HP:0002058) | 1.53618693 |
| 162 | Hyperextensible skin (HP:0000974) | 1.52913201 |
| 163 | Abnormality of the salivary glands (HP:0010286) | 1.52636099 |
| 164 | Osteolytic defects of the hand bones (HP:0009699) | 1.52283527 |
| 165 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.52283527 |
| 166 | Asymmetry of the thorax (HP:0001555) | 1.51408407 |
| 167 | Atrophic scars (HP:0001075) | 1.51321800 |
| 168 | Neoplasm of the heart (HP:0100544) | 1.49229489 |
| 169 | Blue sclerae (HP:0000592) | 1.49034880 |
| 170 | Overgrowth (HP:0001548) | 1.48553559 |
| 171 | Akinesia (HP:0002304) | 1.48494384 |
| 172 | Hemorrhage of the eye (HP:0011885) | 1.47713906 |
| 173 | Metaphyseal cupping (HP:0003021) | 1.46967172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.58355645 |
| 2 | PKN2 | 3.05133820 |
| 3 | PRPF4B | 2.65804342 |
| 4 | ERN1 | 2.62175535 |
| 5 | MAP3K9 | 2.58916917 |
| 6 | KSR2 | 2.28371115 |
| 7 | RIPK1 | 2.12908595 |
| 8 | SIK1 | 2.12414373 |
| 9 | LMTK2 | 1.97144424 |
| 10 | RIPK4 | 1.93121629 |
| 11 | CAMKK1 | 1.89589286 |
| 12 | TTN | 1.86842528 |
| 13 | PDGFRA | 1.79207262 |
| 14 | DAPK2 | 1.71131731 |
| 15 | NTRK1 | 1.69250312 |
| 16 | PRKD3 | 1.67167224 |
| 17 | FGFR4 | 1.62115107 |
| 18 | NEK1 | 1.61776645 |
| 19 | PTK6 | 1.59839408 |
| 20 | RET | 1.55350313 |
| 21 | PAK6 | 1.55229732 |
| 22 | MAP3K2 | 1.54935040 |
| 23 | BCKDK | 1.53538738 |
| 24 | MAP2K4 | 1.49384789 |
| 25 | CAMK1D | 1.45244668 |
| 26 | MARK2 | 1.42262280 |
| 27 | PHKG1 | 1.41408869 |
| 28 | PHKG2 | 1.41408869 |
| 29 | NTRK3 | 1.34818023 |
| 30 | CDK12 | 1.29721232 |
| 31 | CAMK1G | 1.21795992 |
| 32 | MINK1 | 1.21177423 |
| 33 | PRKCH | 1.11624566 |
| 34 | SGK3 | 1.11556862 |
| 35 | CAMKK2 | 1.10128957 |
| 36 | TESK1 | 1.09462049 |
| 37 | STK38 | 1.09005444 |
| 38 | TAOK1 | 1.08113780 |
| 39 | MAPK12 | 1.05730151 |
| 40 | EEF2K | 1.04685061 |
| 41 | MAP3K7 | 1.04292019 |
| 42 | MAP3K4 | 1.04132307 |
| 43 | BMX | 1.01604646 |
| 44 | DDR2 | 1.01555808 |
| 45 | SCYL2 | 1.00175796 |
| 46 | PDK3 | 0.99893038 |
| 47 | PDK4 | 0.99893038 |
| 48 | MAP3K3 | 0.99683584 |
| 49 | SMG1 | 0.99338295 |
| 50 | PAK3 | 0.98348429 |
| 51 | JAK1 | 0.97011647 |
| 52 | FGFR2 | 0.94319624 |
| 53 | TGFBR2 | 0.93387272 |
| 54 | TYRO3 | 0.92571048 |
| 55 | ARAF | 0.91190415 |
| 56 | PRKD2 | 0.89700206 |
| 57 | UHMK1 | 0.88837728 |
| 58 | ZAP70 | 0.88776591 |
| 59 | ALK | 0.88187851 |
| 60 | LATS2 | 0.87920536 |
| 61 | JAK2 | 0.87599495 |
| 62 | PDPK1 | 0.86835173 |
| 63 | MAP3K1 | 0.86014501 |
| 64 | PTK2 | 0.85907423 |
| 65 | FER | 0.85854840 |
| 66 | MAP2K1 | 0.85419982 |
| 67 | FGFR3 | 0.84551024 |
| 68 | MARK1 | 0.83278278 |
| 69 | EPHB1 | 0.82526783 |
| 70 | PDK1 | 0.78903239 |
| 71 | KSR1 | 0.78823696 |
| 72 | MAP3K10 | 0.78736929 |
| 73 | DMPK | 0.73778025 |
| 74 | HIPK2 | 0.73631003 |
| 75 | EPHA2 | 0.72861968 |
| 76 | FLT3 | 0.72074358 |
| 77 | PINK1 | 0.69602221 |
| 78 | MOS | 0.68921497 |
| 79 | LATS1 | 0.68829342 |
| 80 | FRK | 0.68500774 |
| 81 | ICK | 0.67523209 |
| 82 | NEK6 | 0.66155506 |
| 83 | NTRK2 | 0.65275918 |
| 84 | MAP3K6 | 0.62780028 |
| 85 | PDGFRB | 0.62458587 |
| 86 | CDK5 | 0.62180271 |
| 87 | PRKAA1 | 0.61882300 |
| 88 | MYLK | 0.60162469 |
| 89 | SGK494 | 0.59666297 |
| 90 | SGK223 | 0.59666297 |
| 91 | SIK3 | 0.59169231 |
| 92 | EPHA4 | 0.58823920 |
| 93 | TYK2 | 0.58444383 |
| 94 | AKT3 | 0.58182705 |
| 95 | MAPK7 | 0.57415043 |
| 96 | INSRR | 0.57194766 |
| 97 | MAP3K11 | 0.56588804 |
| 98 | TAOK3 | 0.56496884 |
| 99 | TNK2 | 0.55842221 |
| 100 | ROCK2 | 0.55292137 |
| 101 | SIK2 | 0.55272054 |
| 102 | RPS6KA2 | 0.55126616 |
| 103 | FGFR1 | 0.54192337 |
| 104 | PRKD1 | 0.53845959 |
| 105 | PIK3CA | 0.52427600 |
| 106 | MET | 0.52234365 |
| 107 | SGK2 | 0.52111537 |
| 108 | MAPKAPK3 | 0.52029325 |
| 109 | DAPK1 | 0.50615810 |
| 110 | CAMK1 | 0.49656434 |
| 111 | PRKCZ | 0.49328198 |
| 112 | CSK | 0.48675679 |
| 113 | MTOR | 0.48564569 |
| 114 | WNK1 | 0.47144441 |
| 115 | NEK9 | 0.46972007 |
| 116 | GRK5 | 0.46565229 |
| 117 | YES1 | 0.46497368 |
| 118 | MAP3K13 | 0.46421936 |
| 119 | TAOK2 | 0.46370434 |
| 120 | EPHA3 | 0.46282993 |
| 121 | MAPK10 | 0.45688994 |
| 122 | MST1R | 0.45606898 |
| 123 | CDC42BPA | 0.44547536 |
| 124 | PRKACG | 0.42802430 |
| 125 | PTK2B | 0.42619136 |
| 126 | MAP2K3 | 0.42438972 |
| 127 | CAMK4 | 0.41706416 |
| 128 | STK11 | 0.41530962 |
| 129 | TBK1 | 0.41369574 |
| 130 | FYN | 0.39025172 |
| 131 | DYRK1B | 0.38729030 |
| 132 | PAK4 | 0.37374268 |
| 133 | MAPK11 | 0.37351334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.91525250 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.09110024 |
| 3 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.29202177 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.27406611 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.02420488 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.96638668 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.79154836 |
| 8 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.74936633 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.72905833 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.68840783 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.62660685 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.61155245 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.57186155 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.56308689 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.56205616 |
| 16 | Bile secretion_Homo sapiens_hsa04976 | 1.50874823 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.45395712 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.45037482 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.37784030 |
| 20 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.33263986 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.31229658 |
| 22 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.30580536 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.23476828 |
| 24 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.22881158 |
| 25 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.15831020 |
| 26 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.12519662 |
| 27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.08913997 |
| 28 | Insulin resistance_Homo sapiens_hsa04931 | 1.08326397 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06287091 |
| 30 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.05554264 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.04641215 |
| 32 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03023445 |
| 33 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02560256 |
| 34 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.02148488 |
| 35 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.01227808 |
| 36 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.00714516 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.99566527 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.96096501 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.95969639 |
| 40 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.94012672 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.93815298 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.92992651 |
| 43 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.92737916 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.92657293 |
| 45 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.92003351 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.91976837 |
| 47 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.91603891 |
| 48 | Thyroid cancer_Homo sapiens_hsa05216 | 0.90987919 |
| 49 | Adherens junction_Homo sapiens_hsa04520 | 0.90959895 |
| 50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.89584874 |
| 51 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.89216313 |
| 52 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.89131184 |
| 53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.85655292 |
| 54 | Peroxisome_Homo sapiens_hsa04146 | 0.85219878 |
| 55 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83925653 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83809560 |
| 57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.83808889 |
| 58 | Melanogenesis_Homo sapiens_hsa04916 | 0.83215218 |
| 59 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.83121710 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 0.81603003 |
| 61 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.81432134 |
| 62 | Gap junction_Homo sapiens_hsa04540 | 0.81343275 |
| 63 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.79010675 |
| 64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78257119 |
| 65 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.77530188 |
| 66 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76550783 |
| 67 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.76243896 |
| 68 | Insulin secretion_Homo sapiens_hsa04911 | 0.75956476 |
| 69 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.75488908 |
| 70 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.75080377 |
| 71 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.74499096 |
| 72 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.74193190 |
| 73 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.72654089 |
| 74 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.72344755 |
| 75 | Glioma_Homo sapiens_hsa05214 | 0.72043437 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71916910 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71553469 |
| 78 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.71347761 |
| 79 | * Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.71168003 |
| 80 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71138084 |
| 81 | Cocaine addiction_Homo sapiens_hsa05030 | 0.71109033 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70922492 |
| 83 | Lysosome_Homo sapiens_hsa04142 | 0.70772956 |
| 84 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70533032 |
| 85 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.70285697 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.69175291 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68771099 |
| 88 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.68487400 |
| 89 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.68390836 |
| 90 | Prion diseases_Homo sapiens_hsa05020 | 0.68212598 |
| 91 | Olfactory transduction_Homo sapiens_hsa04740 | 0.67519630 |
| 92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.66349017 |
| 93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.66143983 |
| 94 | Tight junction_Homo sapiens_hsa04530 | 0.65944125 |
| 95 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.65801929 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.65272444 |
| 97 | Lysine degradation_Homo sapiens_hsa00310 | 0.64972247 |
| 98 | Long-term depression_Homo sapiens_hsa04730 | 0.64233754 |
| 99 | Axon guidance_Homo sapiens_hsa04360 | 0.64133892 |
| 100 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.63796611 |
| 101 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62268576 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61980005 |
| 103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60799456 |
| 104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60080673 |
| 105 | GABAergic synapse_Homo sapiens_hsa04727 | 0.59387009 |
| 106 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.59106025 |
| 107 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58839260 |
| 108 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.58812420 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58622303 |
| 110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58598268 |
| 111 | Prostate cancer_Homo sapiens_hsa05215 | 0.58267028 |
| 112 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56544360 |
| 113 | Circadian entrainment_Homo sapiens_hsa04713 | 0.55239646 |
| 114 | Long-term potentiation_Homo sapiens_hsa04720 | 0.54649433 |
| 115 | Salivary secretion_Homo sapiens_hsa04970 | 0.51793744 |
| 116 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51722747 |
| 117 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51719263 |
| 118 | Renin secretion_Homo sapiens_hsa04924 | 0.51536030 |
| 119 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50500127 |
| 120 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.50190162 |
| 121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50138273 |
| 122 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.48519956 |
| 123 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48123798 |
| 124 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47396425 |
| 125 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.47303502 |
| 126 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47138285 |
| 127 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.47105154 |
| 128 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44658903 |
| 129 | Focal adhesion_Homo sapiens_hsa04510 | 0.44307176 |
| 130 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.43263362 |
| 131 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.42974218 |
| 132 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42522429 |
| 133 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42185112 |
| 134 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41636056 |
| 135 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41056599 |
| 136 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40942722 |
| 137 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40825782 |
| 138 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39820469 |
| 139 | * Amoebiasis_Homo sapiens_hsa05146 | 0.39721999 |
| 140 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.38630172 |
| 141 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.38509357 |
| 142 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.38154307 |
| 143 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.37744226 |
| 144 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.36813387 |
| 145 | * Endocytosis_Homo sapiens_hsa04144 | 0.35879479 |

